CELLULAR LIFT REGENERATION (CLR)
LIVE

Serial Number

79429030

Owner

Dr. Christoph Karl

Attorney

W. Tyler Hall

Filing Date

Jun 5, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CELLULAR LIFT REGENERATION (CLR) Trademark

Serial Number: 79429030 • Registration: 8407650

CELLULAR LIFT REGENERATION (CLR) is a trademark filed by Dr. Christoph Karl on June 5, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

Dr. Christoph Karl (3 trademarks)

Haldenstraße 1

Entity Type: 01

Trademark Details

Filing Date

June 5, 2025

Registration Date

August 25, 2026

Published for Opposition

July 7, 2026

Goods & Services

Pharmaceuticals and veterinary preparations, in particular for the prevention and treatment of cartilage and bone diseases; chemicals for medical purposes, in particular for the prevention and treatment of cartilage and bone diseases; biological preparations for use in cell cultures for medical purposes; medicines for use in human and veterinary medicine for the treatment of bone diseases, osteoarthritis, cartilage defects, arthrosis and traumatic cartilage injuries; drug delivery agents in the form of tablets, capsules, pastilles, and granules that facilitate the delivery of pharmaceutical preparations; ointments for pharmaceutical purposes for the treatment of bone diseases, osteoarthritis, cartilage defects, arthrosis and traumatic cartilage injuries; injection solutions for pharmaceutical purposes for the treatment of bone diseases, osteoarthritis, cartilage defects, arthrosis and traumatic cartilage injuries; dietetic foods and beverages adapted for use in human and veterinary medicine; therapeutic food for dietetic medical purposes; medicinal drinks; dietary supplements, in particular for medical purposes; vitamin and multi-vitamin preparations, in particular for medical purposes; mineral supplements and mineral preparations, in particular for medical purposes; biological and chemical preparations for medical diagnostic purposes for use in laboratories, pharmacies and doctors' surgeries; chemical test preparations for medical diagnostic purposes, in particular reagents, standard solutions, biological indicators and cell culture media; pre-filled syringes sold filled with cell growth factors, analgesics, hyaluronic acid and its derivates, vitamins and minerals

Surgical apparatus and instruments; medical and dental apparatus and instruments, namely, arthroscopic trocar, arthroscopic working sleeves, arthroscopic drills and arthroscopic plungers; vials sold empty for the purpose of medical infusions; medical analytical apparatus, namely, X-ray apparatus, computed tomography apparatus, magnetic resonance imaging apparatus and arthroscopes; implants consisting of artificial materials for use in human and veterinary medicine, in particular for the prevention and treatment of cartilage and bone diseases

Printed matter, namely brochures for patients and magazines with advertising, including for pharmacies and doctors, all the aforesaid relating to the prevention and treatment of cartilage and bone diseases

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 25, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 25, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 7, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jul 7, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 1, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 11, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 11, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Jun 11, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Jun 11, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 11, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 10, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 10, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 10, 2026 TROA
REFUSAL PROCESSED BY IB
Dec 25, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 10, 2025 RFCS
REFUSAL PROCESSED BY MPU
Dec 10, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 1, 2025 RFCR
NON-FINAL ACTION WRITTEN
Oct 31, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 24, 2025 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Sep 5, 2025 NREP
APPLICATION FILING RECEIPT MAILED
Aug 1, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 1, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 31, 2025 REPR